Immune-Onc Therapeutics Employee Directory

Biotechnology ResearchUnited States11-50 Employees

Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a private, clinical-stage oncology company dedicated to discovering and developing novel biotherapeutics targeting myeloid cell inhibitory receptors. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies.

Immune-Onc has a differentiated pipeline with a current focus on targeting the Leukocyte Immunoglobulin-Like Receptor subfamily B (LILRB). Immune-Onc’s focused platform approach has led to the development of several promising therapeutics across various stages of development. Those include IO-108, an antagonist antibody targeting LILRB2 (also known as ILT4), in Phase 1b/2 clinical development for solid tumors, and IO-202, a first-in-class antagonist antibody targeting LILRB4 (also known as ILT3), in Phase 1b clinical development for the treatment of acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and solid tumors. Additional assets in Immune-Onc’s pipeline include IO-106 (first-in-class antagonist antibody targeting LAIR1), IO-312 (a novel bispecific antibody targeting LILRB4 and CD3), and undisclosed immunology and oncology programs. For more information, please visit www.immune-onc.com.

Find Immune-Onc Therapeutics employees' phone numbers or email addresses

Immune-Onc Therapeutics Global Highlights

North America
19

United States Of America
19

Asia
4

China
3
India
1

Immune-Onc Therapeutics's Leadership

L. W.
Vice President, Head Of Clinical Operations
Mobile Phone
Email
S. Y.
Director Of Hr And Operations (china)
Mobile Phone
Email
S. R.
Senior Clinical Project Manager
Mobile Phone
Email
M. G.
China General Manager
Mobile Phone
Email
A. S.
Human Resources Manager
Mobile Phone
Email
S. W.
Senior Clinical Trial Manager
Mobile Phone
Email
C. L.
Chairperson Of The Board
Mobile Phone
Email
J. D.
Board Member
Mobile Phone
Email

Immune-Onc Therapeutics Employee Metrics

100%

50%

0%

2025

2024

Engineering
Operations
Program & Project Management
Research
Administrative
Other
Consultant
Human Resources

Contact profiles from Immune-Onc Therapeutics

Name

Title

Contact Info

Location

Last Update

J. H.
Officer
Mobile Phone
Email
Oct 23, 2024

Frequently Asked Questions

What is Immune-Onc Therapeutics known for?

Immune-Onc Therapeutics was founded in 2016 operates in the Biotechnology Research industry. The company's main headquarters is located in 795 San Antonio Rd, Palo Alto, California 94303, US; you can contact the main corporate office by phone at

+1-650-460-****

. Explore Immune-Onc Therapeutics's company overview page for more information.

What is Immune-Onc Therapeutics's most common email format?

Immune-Onc Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Immune-Onc Therapeutics email formats with LeadIQ.

How many employees does Immune-Onc Therapeutics have currently?

Immune-Onc Therapeutics has approximately 18 employees as of October 2025. These team members are located across 2 continents, including North AmericaAsia.

Who are Immune-Onc Therapeutics's key employees and leadership?

As of October 2025, Immune-Onc Therapeutics's key employees include:

Vice President, Head Of Clinical Operations: L. W.
Director Of Hr And Operations (china): S. Y.
Senior Clinical Project Manager: S. R.
China General Manager: M. G.
Human Resources Manager: A. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking